The Nobel Prize in Physiology or Medicine 2002     
  Robert Horvitz
Robert Horvitz, born 1947,
Cambridge, MA, USA.

Robert Horvitz used C. elegans to investigate whether
there was a genetic programme controlling cell death.
In 1986, he identified the first two "death genes", ced-3
and ced-4. He showed that functional ced-3 and ced-4
genes were a prerequisite for cell death to be executed.
Later, Horvitz discovered that another gene, ced-9, protects
against cell death by interacting with ced-4 and ced-3.
He also identified genes directing the elimination of the
dead cell, and he showed that the human genome contains
a ced-3-like gene.

We now know that most genes involved in controlling
cell death in C. elegans have counterparts in humans and
are evolutionarily well conserved. In the human signalling
pathway ced-3-, ced-4- and ced-9-like molecules

Robert Horvitz identified genes controlling cell death in C. elegans. Corresponding genes exist in mammals, including man.
|The Nobel Prize in Physiology or Medicine 2002 | Introduction | Sydney BrennerRobert Horvitz|
John Sulston
| The Implications of the Discoveries | Credits |
Nobel Poster from the Nobel Committee for Physiology or Medicine, web adapted by Nobel Web

Copyright © Nobel Media AB 2017